Analysts Issue Forecasts for FDMT FY2026 Earnings
4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Free Report) – Stock analysts at Cantor Fitzgerald issued their FY2026 earnings per share (EPS) estimates for shares of 4D Molecular Therapeutics in a note issued to investors on Monday, June 9th. Cantor Fitzgerald analyst J. Schimmer anticipates that the company will post earnings of ($2.86) per share for […]
4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Free Report) – Stock analysts at Cantor Fitzgerald issued their FY2026 earnings per share (EPS) estimates for shares of 4D Molecular Therapeutics in a note issued to investors on Monday, June 9th. Cantor Fitzgerald analyst J. Schimmer anticipates that the company will post earnings of ($2.86) per share for […]
